Searched for
AFFORDABLE HIV PREVENTION
Generic HIV drug rollout to take a hit on trial pushIndia's decision to reject a waiver for local clinical trials of a new HIV drug, lenacapavir, is causing concern. Public health experts war...- Indian drugmakers Dr Reddy's, Hetero to sell generic HIV prevention drug for $40 a yearIndian drugmakers, Dr Reddy's and Hetero Labs, will offer generic HIV prevention drugs. The price will be around $40 yearly from 2027. This...
- Aurobindo to produce, supply long acting HIV treatment drugAurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...
- Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a yearA twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by mid-2026. Develope...
- A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why?The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 lakh, hinderi...
- US approves Gilead's twice-yearly injection to prevent HIVThe US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hail...
- Twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's twice-yearly HIV prevention shot was 100% effective in women and almost as good in men. The company will offer cheap generic versi...
- New HIV cases down by 44% since 2010: Anupriya PatelNew annual HIV infections in India have decreased by 44 per cent since 2010, surpassing the global reduction rate of 39 per cent. Union Min...
- Activists sound alarm bells as Gilead seeks rights over HIV drugLenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...
- Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'The shots made by U.S. drugmaker Gilead and sold as Sunlenca are approved in the U.S., Canada, Europe and elsewhere, but only as a treatmen...
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...
- High court directs Delhi govt to provide free food, treatment to HIV-positive personsThe court's order was passed on a petition by persons suffering from HIV/AIDS and other multiple disabilities and ailments and had been aba...
- India calls for flexibilities in IPR to combat AIDSJP Nadda said India will need to "front load" its investments substantially to almost double the number of people on ARV treatment in less ...
- How modern medicine is keeping HIV in checkThe stigma of HIV remains. But with modern medicines, Charlie Sheen and others infected by the virus can lead a normal life.
- Indian, African experts to participate in HIV-AIDS conferenceExperts from India and East African nations will brainstorm ways to accelerate new preventive technologies for HIV-AIDS and to ensure great...
- HIV model can beat hepatitis, say doctorsOn World Hepatitis Day on Monday, World Health Organization called for using similar strategies and infrastructure to check the spread of i...
- Government to set up 10 labs for hepatitis surveillanceGovernment will set up ten regional laboratories through the National Communicable Disease Centre (NCDC) for the surveillance of viral hepa...
- 96,000 die every year due to Hepatitis C in India: ReportThe report said the prevalence of Hepatitis C is estimated to be within 1.8-2.5 per cent, while among drug users it is 50-90 per cent.
- Ranbaxy arm bags Rs 605 cr anti-HIV drug order in South AfricaThe 913.5 million rand order bagged by Sonke is a part of a 4.28 billion rand national anti-retroviral tender floated by the South African ...
- Strides Arcolab gets US nod for anti-HIV drugPharmaceutical company, Strides Arcolab has received tentative approval from the United States Food and Drug Administration (USFDA) for Efa...
Load More
